This announcement is a separate document:
Macrogenics | DEF 14A: Definitive proxy statements
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
18:22
HSBC stated that the forecast for Brent crude oil product in 2025 and beyond remains at $70 per barrel.
HSBC+1.50%
18:21
Swissquote Bank: The market seems indifferent to OPEC+'s decision.
18:20
Imeik Technology Development: A subsidiary has received approval for clinical trials of recombinant human hyaluronidase injection.
Imeik Technology Development+3.22%